Biontech Stocks - Search News

2 Artificial Intelligence (AI) Stocks With Seemingly Impenetrable Moats That Can Have Their Palantir Moment in 2025

Artificial intelligence (AI) is already transforming many industries, but not all tech companies will benefit equally. The companies with the most potential notched their AI lead

Zacks.com on MSN · 22h

Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know

BioNTech SE Sponsored ADR (BNTX) closed the last trading session at $112.76, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide.

AOL · 1d

Prediction: These 3 Artificial Intelligence (AI) Chip Stocks Will Crush the Market in 2025

The semiconductor industry has received a major shot in the arm from the rapid advancement of artificial intelligence (AI) technology: The size of the semiconductor market jumped by an estimated 19% last year to $630 billion,

The Motley Fool · 1h

This Artificial Intelligence (AI) Stock Is Already Down 10% in 2025, but Wall Street Analysts Believe That It Could Soar Impressively

Enterprise artificial intelligence (AI) software provider C3.ai ( AI -0.93%) is off to a shaky start in 2025. Shares of the company have fallen 10% this year, though there has been no company-specific news of note that could have triggered this pullback.

Why BioNTech (BNTX) Shares Are Volatile Today

Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna's updated revenue guidance for 2025, which ...

Goldman Sachs Sticks to Their Buy Rating for BioNTech SE (BNTX)

In a report released today, Chris Shibutani from Goldman Sachs maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...

BioNTech SE ADR rises Friday, outperforms market

BioNTech SE ADR closed $8.64 short of its 52-week high ($131.49), which the company achieved on September 17th.

BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst

Truist rates BioNTech a Buy, citing its shift to oncology with BNT327 leading the way. Key data updates and growth catalysts ...

Truist Financial Issues a Buy Rating on BioNTech SE (BNTX)

In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to BioNTech SE (BNTX – Research Report). The ...

14d

5 Predictions for the Stock Market in 2025 -- and Which Stocks Will Soar the Most If They're Right

I made four predictions about the stock market in 2024. The Fed indeed cut rates in Q4, but stocks didn't jump as much as I ...

stocknews11d

3 Genomic Stocks Unlocking the Secrets of DNA

Genomics is becoming the future of medicine as technological advancements continue to unlock our DNA’s vast potential. Given ...

24d

BioNTech SE ADR rises Tuesday, still underperforms market

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Yahoo Finance20d

If You’d Invested In These 5 Stocks Before the Last Inauguration Day, Here’s How Much They’d Be Worth Now

Unfortunately, as the pandemic eased, the Pfizer stock began to suffer. BioNTech was anticipated to enjoy the same Biden boost as headline vaccine producer Pfizer, thanks to the state of the ...

17d

Geode Capital Management LLC Lowers Stock Position in BioNTech SE (NASDAQ:BNTX)

Geode Capital Management LLC trimmed its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 0.8% during the 3rd quarter, ...

Seeking Alpha21d

BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claims

BioNTech (NASDAQ:BNTX) announced Friday two separate agreements worth more than $1B with the National Institutes of Health (NIH) and the University of Pennsylvania to resolve royalty and other ...

BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results